Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase III Aridol study enrolls first patients

Dec. 16, 2005

NDA submission for arformoterol for COPD

Dec. 14, 2005

Xopenex HFA now available

Dec. 14, 2005

Novel therapeutic agents for allergic disorders prepared and tested

Dec. 13, 2005

PTC-124 begins phase II study for cystic fibrosis with FDA funding

Dec. 12, 2005

R-112 disappoints in phase II comparative study in allergic rhinitis

Dec. 7, 2005

Recent GSK patent imparts novel agents for respiratory disorders

Dec. 2, 2005

Bosentan studies in pulmonary fibrosis show no effect on primary exercise endpoint

Nov. 29, 2005

Medivir and Jiangsu Hengrui Medicine Company extend COPD collaboration

Nov. 29, 2005

Recent patents report novel treatment options for respiratory disorders

Nov. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....